SCHEMBL2493486

SCHEMBL2493486

Cc1ccccc1C(OCCN)(c1ccccc1)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.68
SMN1; SMN2 Q16637 1/20 0.41
TK2 O00142 7/20 0.38
TK1 P04183 2/20 0.37
TAAR1 Q96RJ0 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2493523 0.90 KIF11 (0.54) KIF11SMN1; SMN2TK2TK1
SCHEMBL2490388 0.90 KIF11 (0.55) KIF11SMN1; SMN2TAAR1
SCHEMBL2491620 0.83 KIF11 (0.44) KIF11TK2TK1
SCHEMBL2492363 0.82 KIF11 (1.00) KIF11SMN1; SMN2TK2TK1TAAR1
SCHEMBL2492907 0.81 KIF11 (0.70) KIF11SMN1; SMN2TAAR1
SCHEMBL2489201 0.81 KIF11 (0.42) KIF11TK2TK1
SCHEMBL2489422 0.81 KIF11 (0.64) KIF11SMN1; SMN2TAAR1
SCHEMBL2489288 0.79 KIF11 (0.43) KIF11TK2TK1TAAR1
SCHEMBL12199498 0.79 KIF11 (0.79) KIF11SMN1; SMN2TK2TK1
SCHEMBL1314333 0.77 KIF11 (0.38) KIF11TK2TK1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KIF11 4556/4885SMN1; SMN2 3632/4885TK2 2689/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KIF11 4605/4885SMN1; SMN2 3663/4885TK2 2492/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KIF11 4611/4885SMN1; SMN2 3592/4885TK2 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.